Analysts Set The Clorox Company (NYSE:CLX) Target Price at $125.00

The Clorox Company (NYSE:CLX) has received a consensus recommendation of “Reduce” from the eighteen brokerages that are currently covering the company, Marketbeat Ratings reports. Four investment analysts have rated the stock with a sell rating, thirteen have issued a hold rating and one has issued a buy rating on the company. The average 1 year price objective among brokerages that have covered the stock in the last year is $125.00.

A number of research firms have recently weighed in on CLX. Rothschild & Co Redburn dropped their price target on shares of Clorox from $120.00 to $115.00 and set a “neutral” rating for the company in a research report on Wednesday, November 5th. Barclays lowered their price objective on Clorox from $112.00 to $108.00 and set an “underweight” rating on the stock in a research note on Tuesday, November 4th. Citigroup cut their target price on Clorox from $120.00 to $109.00 and set a “neutral” rating for the company in a research report on Wednesday. The Goldman Sachs Group decreased their price target on Clorox from $115.00 to $110.00 and set a “sell” rating on the stock in a research report on Wednesday, October 1st. Finally, Wells Fargo & Company cut their price objective on shares of Clorox from $125.00 to $117.00 and set an “equal weight” rating for the company in a research report on Tuesday, November 4th.

Clorox Stock Down 1.1%

CLX opened at $98.31 on Thursday. The stock has a fifty day moving average of $107.92 and a 200-day moving average of $118.15. The company has a market capitalization of $11.99 billion, a P/E ratio of 15.43, a P/E/G ratio of 0.49 and a beta of 0.57. Clorox has a fifty-two week low of $98.20 and a fifty-two week high of $165.00. The company has a debt-to-equity ratio of 18.01, a quick ratio of 0.50 and a current ratio of 0.76.

Clorox (NYSE:CLX) last released its quarterly earnings results on Monday, November 3rd. The company reported $0.85 EPS for the quarter, topping analysts’ consensus estimates of $0.78 by $0.07. Clorox had a net margin of 11.68% and a return on equity of 358.39%. The business had revenue of $1.43 billion for the quarter, compared to analyst estimates of $1.41 billion. During the same period last year, the firm earned $1.86 earnings per share. Clorox’s revenue for the quarter was down 18.9% compared to the same quarter last year. Clorox has set its FY 2026 guidance at 5.950-6.300 EPS. On average, equities analysts expect that Clorox will post 7.15 EPS for the current year.

Clorox Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, February 13th. Stockholders of record on Wednesday, January 28th will be issued a dividend of $1.24 per share. This represents a $4.96 dividend on an annualized basis and a dividend yield of 5.0%. The ex-dividend date of this dividend is Wednesday, January 28th. Clorox’s dividend payout ratio is 77.86%.

Insider Transactions at Clorox

In other news, Director Pierre R. Breber acquired 4,000 shares of the firm’s stock in a transaction that occurred on Friday, November 21st. The shares were acquired at an average cost of $104.13 per share, with a total value of $416,520.00. Following the completion of the purchase, the director directly owned 13,000 shares of the company’s stock, valued at $1,353,690. The trade was a 44.44% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 0.63% of the stock is owned by company insiders.

Institutional Investors Weigh In On Clorox

Large investors have recently modified their holdings of the business. Public Sector Pension Investment Board lifted its position in shares of Clorox by 7.2% during the 1st quarter. Public Sector Pension Investment Board now owns 16,644 shares of the company’s stock worth $2,451,000 after buying an additional 1,122 shares during the last quarter. Dimensional Fund Advisors LP lifted its holdings in shares of Clorox by 0.6% in the first quarter. Dimensional Fund Advisors LP now owns 936,393 shares of the company’s stock worth $137,879,000 after acquiring an additional 5,365 shares during the last quarter. American Century Companies Inc. boosted its stake in shares of Clorox by 46.9% in the 1st quarter. American Century Companies Inc. now owns 112,199 shares of the company’s stock valued at $16,521,000 after purchasing an additional 35,799 shares in the last quarter. Raymond James Financial Inc. grew its holdings in shares of Clorox by 15.6% during the 1st quarter. Raymond James Financial Inc. now owns 269,926 shares of the company’s stock valued at $39,747,000 after purchasing an additional 36,352 shares during the last quarter. Finally, Northern Trust Corp increased its position in Clorox by 2.3% during the 1st quarter. Northern Trust Corp now owns 1,528,920 shares of the company’s stock worth $225,133,000 after purchasing an additional 34,655 shares in the last quarter. Institutional investors and hedge funds own 78.53% of the company’s stock.

About Clorox

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.